# 25-hydroxyvitamin D as a predictor of reduced heart rate variability in elderly patients with diabetes mellitus

**Authors:** Tiantian Tang, Xinyu Sun, Xiaoxiang Zhang, Jiaojiao Li, Manjie Wang, Cancan Hui, Yuwei Cheng, Xiaoming Kong, Yan Sun

PMC · DOI: 10.3389/fendo.2025.1556345 · Frontiers in Endocrinology · 2025-04-30

## TL;DR

This study finds that low vitamin D levels may predict reduced heart rate variability in elderly diabetes patients.

## Contribution

The study identifies 25-hydroxyvitamin D as a novel predictor of reduced heart rate variability in elderly diabetic patients.

## Key findings

- Lower 25-(OH)D levels are associated with decreased heart rate variability in elderly diabetic patients.
- 25-(OH)D is identified as an independent risk factor for reduced HRV alongside other metabolic markers.
- The study suggests 25-(OH)D could serve as an early predictive marker for HRV reduction.

## Abstract

To analyze the risk factors for decreased heart rate variability (HRV) in elderly diabetic patients and evaluate the predictive value of 25-hydroxyvitamin D [25-(OH)D].

A retrospective study was conducted, enrolling 101 elderly diabetic patients admitted to the Department of Geriatric Endocrinology at the First Affiliated Hospital of Anhui Medical University from 2023 to 2024. Patients were divided into two groups based on the standard deviation of all normal RR intervals (SDNN) from 24-hour Holter monitoring: the normal HRV group (180 ms ≥ SDNN ≥ 100 ms) and the decreased HRV group (SDNN < 100 ms). Clinical data collected included age, sex, body mass index (BMI), Diabetic peripheral neuropathy (DPN), Diabetic peripheral vascular disease (DPVD), Diabetic nephropathy (DN), Diabetic retinopathy (DR), as well as laboratory parameters such as fasting plasma glucose (FPG), glycated hemoglobin (HbA1c), creatinine (Cr), glomerular filtration rate (GFR), uric acid (UA), cystatin C (CysC), total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), very-low-density lipoprotein cholesterol (VLDL-C), non-HDL-C, 25-(OH)D, 24-hour urinary total protein (24hUTP), 24-hour urinary uric acid (24hUA), microalbuminuria (MAlb), urinary albumin-to-creatinine ratio (UACR), and calculated ratios including TG/HDL-C, UA/HDL-C, and non-HDL-C/HDL-C. Statistical analyses included χ² test, independent t-test, Mann-Whitney U test, and multivariate logistic regression to identify risk factors for HRV reduction. Receiver operating characteristic (ROC) curve analysis was performed to assess the predictive value of these factors.

Compared with the normal HRV group, the decreased HRV group had significantly lower HDL-C and 25-(OH)D levels but higher prevalence of DN, along with elevated 24hUTP, MAlb, UACR, TG/HDL-C, and UA/HDL-C (all P < 0.05). These factors were identified as independent risk factors for HRV reduction in elderly diabetic patients.

This study identified key risk factors for HRV reduction in elderly diabetic patients. Furthermore, 25-(OH)D levels may serve as an early predictive marker for decreased HRV in this population.

## Linked entities

- **Chemicals:** 25-hydroxyvitamin D (PubChem CID 5353325), creatinine (PubChem CID 588), uric acid (PubChem CID 1175)
- **Diseases:** diabetes mellitus (MONDO:0005015), diabetic nephropathy (MONDO:0005016), diabetic retinopathy (MONDO:0005266)

## Full-text entities

- **Genes:** REN (renin) [NCBI Gene 5972] {aka ADTKD4, HNFJ2, RTD}, KIR2DL4 (killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 4) [NCBI Gene 3805] {aka CD158D, G9P, KIR-103AS, KIR-2DL4, KIR103, KIR103AS}, KCNH2 (potassium voltage-gated channel subfamily H member 2) [NCBI Gene 3757] {aka ERG-1, ERG1, H-ERG, HERG, HERG1, Kv11.1}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, PTH (parathyroid hormone) [NCBI Gene 5741] {aka FIH1, PTH1}, CST3 (cystatin C) [NCBI Gene 1471] {aka ADLDWA, ARMD11, HEL-S-2}, KCNQ1 (potassium voltage-gated channel subfamily Q member 1) [NCBI Gene 3784] {aka ATFB1, ATFB3, JLNS1, KCNA8, KCNA9, KVLQT1}, TH (tyrosine hydroxylase) [NCBI Gene 7054] {aka DYT14, DYT5b, TYH}
- **Diseases:** rheumatic heart disease (MESH:D012214), Cushing's syndrome (MESH:D003480), respiratory diseases (MESH:D012140), DR (MESH:D003930), cognitive impairment (MESH:D003072), DPVD (MESH:D016491), Parkinson's disease (MESH:D010300), DCAN (MESH:D003929), hepatic or renal dysfunction (MESH:D008107), insulin resistance (MESH:D007333), cerebrovascular diseases (MESH:D002561), cardiovascular autonomic neuropathy (MESH:D002318), neuropsychiatric disorders (MESH:D001523), acute coronary syndrome (MESH:D054058), DN (MESH:D003928), cardiorenal syndrome (MESH:D059347), autonomic neuropathy (MESH:D009422), Diabetic nephropathyl (MESH:D003920), valvular heart disease (MESH:D006349), trauma (MESH:D014947), hyperthyroidism (MESH:D006980), atherosclerosis (MESH:D050197), pancreatic diseases (MESH:D010182), metabolic disorders (MESH:D008659), autonomic nerve dysfunction (MESH:D005155), CAD (MESH:D003324), inflammatory (MESH:D007249), acute or chronic heart failure (MESH:D017114), autonomic (MESH:D001342), DPN (MESH:D010523), vitamin D (MESH:D014808), HF (MESH:D006333), infections (MESH:D007239), acute inflammatory demyelinating polyneuropathy (MESH:D020275), cardiomyopathy (MESH:D009202), congenital heart disease (MESH:D006330), HRV (MESH:D006331)
- **Chemicals:** Vitamin D (MESH:D014807), NE (MESH:D009638), epinephrine (MESH:D004837), 25(OH)D (-), lipid (MESH:D008055), calcitriol (MESH:D002117), caffeine (MESH:D002110), UA (MESH:D014527), TG (MESH:D014280), cholesterol (MESH:D002784), glucose (MESH:D005947), 25-hydroxyvitamin D (MESH:C104450), NO (MESH:D009569), Cr (MESH:D003404), ACh (MESH:D000109), aldosterone (MESH:D000450)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12074973/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12074973/full.md

## References

31 references — full list in the complete paper: https://tomesphere.com/paper/PMC12074973/full.md

---
Source: https://tomesphere.com/paper/PMC12074973